GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (BSP:N1VO34) » Definitions » Fees and Other Income

Novo Nordisk A/S (BSP:N1VO34) Fees and Other Income


View and export this data going back to 2020. Start your Free Trial

What is Novo Nordisk A/S Fees and Other Income?

Fees and Other Income only applies to insurance companies.


Novo Nordisk A/S (BSP:N1VO34) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.